Binche Pharma SRL
5.4 FTEBinche Pharma reported total assets of €1.51m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 5.4 full-time equivalents.
The score of Binche Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1970 % Total assets -24 % Headcount (avg FTE) +2 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Binche Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Dec 2023
Binche Pharma's financial analysis
- Solvency6.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Binche Pharma
Binche Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0767.986.810
- VAT number
- BE0767986810
- Peppol
- Registered · 0208:0767986810 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 May 2021
- Registered office
- 7130 Binche
- Size
- Micro · 5.4 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Binche Pharma (SRL) has been based in Binche since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 5,516 € and equity of 96,756 €; its revenue is not published. With 5.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 6.4%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Binche Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Mees Retail sale of pharmaceutical products Binche · balance sheet €1.51m
- Apotheek Cnudde Retail sale of pharmaceutical products Waregem · balance sheet €1.51m
- Pharmart Retail sale of pharmaceutical products Etterbeek · balance sheet €1.51m
- De Luchthaven Apotheek Retail sale of pharmaceutical products Zaventem · balance sheet €1.50m
- Apoteek Toelen Retail sale of pharmaceutical products Sint-Pieters-Leeuw · balance sheet €1.51m
- Pharmacies Biot-Gyselinck Retail sale of pharmaceutical products Faimes · balance sheet €1.51m
- Marephar Retail sale of pharmaceutical products Lichtervelde · balance sheet €1.49m
- D5-Pharma Retail sale of pharmaceutical products Ganshoren · balance sheet €1.49m
Frequently asked questions about Binche Pharma
What is the revenue of Binche Pharma?
Binche Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Binche Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0767986810 for Binche Pharma, if the company is VAT-registered. Its company number (CBE) is 0767.986.810.
Where is the registered office of Binche Pharma?
According to the CBE register, the registered office of Binche Pharma is in 7130 Binche.
What is the equity of Binche Pharma?
At the close of the 2025 financial year, the equity of Binche Pharma amounts to 96,756 €, a solvency of 6.4% of total assets.
How many people work at Binche Pharma?
5.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Binche Pharma?
The register lists 2 active mandates at Binche Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Binche Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →